NBEO Part I key terms

Fluid accumulation within the corneal stroma that disrupts the regular spacing of collagen lamellae, producing haze and thickening; often follows endothelial failure or epithelial injury and can progress to bullae.

Single layer of nonrenewing neural-crest-derived cells on the posterior cornea that pump fluid out of the stroma via Na+/K+-ATPase, maintaining relative deturgescence and transparency throughout life.

Thick basement membrane secreted by corneal endothelial cells, composed largely of type IV collagen; it resists trauma but may rupture in congenital glaucoma or forceps injury, and thickens with age.

Porous tissue at the anterior chamber angle through which aqueous humor exits into Schlemm canal; its resistance to outflow is the main determinant of intraocular pressure and the target of many glaucoma therapies.

Balance between aqueous production by the ciliary epithelium and outflow through trabecular and uveoscleral routes; imbalance raises intraocular pressure and underlies most glaucomatous optic neuropathy.

Circumferential venous channel in the sclera just external to the trabecular meshwork that collects aqueous humor and drains it into episcleral veins; its collapse or obstruction reduces outflow facility.

Light-activated sequence in photoreceptors where rhodopsin activates transducin, lowering cGMP and closing cyclic-nucleotide-gated channels, hyperpolarizing the cell and reducing glutamate release to bipolar cells.

G-protein-coupled visual pigment in rod outer segments made of opsin bound to 11-cis-retinal; photon absorption isomerizes retinal to all-trans, triggering the phototransduction cascade and generating the rod response.

Steady inward sodium and calcium current through cGMP-gated channels in darkness that keeps photoreceptors depolarized and continuously releasing glutamate; light suppresses this current, producing hyperpolarization.

Developmental window during which abnormal visual experience, such as deprivation or strabismus, can permanently alter cortical visual circuitry; its timing guides amblyopia screening and treatment decisions in children.

Cortical visual impairment from inadequate early visual input or binocular competition, with reduced acuity not explained by structural ocular disease; treatment is most effective before the critical period closes.

Clinically meaningful difference in refractive error between the two eyes; unequal retinal image blur can disrupt binocular development and cause anisometropic amblyopia, especially with hyperopic differences.

Active increase in crystalline lens power produced by ciliary muscle contraction, which relaxes zonules and allows the lens to become more convex for near vision; amplitude declines with age.

Age-related loss of accommodative amplitude from lens sclerosis and capsule stiffening, typically becoming symptomatic in the fifth decade; corrected with reading adds, multifocal lenses, or surgical approaches.

Disjunctive eye movement in which the visual axes converge or diverge to maintain single binocular vision; driven by disparity, blur, and proximal cues and tightly linked to accommodation.

Depth perception derived from horizontal retinal disparity between the two eyes, processed by cortical disparity-selective neurons; it requires reasonably aligned eyes and comparable image quality.

Clinical measure of visual resolution expressed as the distance at which a patient identifies optotypes relative to the distance at which a standard observer would; affected by optical blur and neural factors.

Curve relating detection threshold to spatial frequency, peaking at intermediate frequencies; it captures visual performance that Snellen acuity misses in disease such as glaucoma or optic neuritis.

Fundamental optical limit on image sharpness from light bending at the pupil aperture; smaller pupils sharpen images until diffraction dominates, which is why very small pupils degrade resolution.

Optical defect in which peripheral rays focus differently from paraxial rays, blurring the retinal image; the human eye typically shows positive spherical aberration that increases with pupil dilation.

Region between the two focal lines produced by astigmatic optics, where no single sharp focus exists; its length and position explain the blur circle and meridional blur in uncorrected astigmatism.

Refractive condition in which power varies across meridians, usually because the cornea is toroidal, so light forms two focal lines rather than a point; corrected with cylindrical or toric lenses.

Smallest angular separation at which two points can be distinguished as separate; it quantifies resolution and relates to cone spacing and optical quality in the fovea.

Sequence of plasma proteins amplifying immune attack through opsonization, lysis, and inflammation; dysregulation contributes to ocular disease such as age-related macular degeneration and atypical hemolytic uremic syndrome.

Rapid, nonspecific defense including barriers, phagocytes, natural killer cells, and complement; in the eye it mediates acute inflammation and interacts with immune privilege to limit tissue damage.

Reduced immune responsiveness in sites such as the anterior chamber and subretinal space, maintained by barriers, immunosuppressive factors, and tolerance mechanisms; it limits inflammation but can permit tumor survival.

Bilateral granulomatous panuveitis following penetrating injury to one eye, believed to be T-cell-mediated autoimmunity against uveal antigens; prompt anti-inflammatory treatment and sometimes enucleation are considered.

Chronic inflammatory pattern featuring collections of activated macrophages and multinucleated giant cells, seen in sarcoidosis, tuberculosis, and fungal disease; it often produces nodular ocular lesions.

Cheese-like tissue destruction within granulomas, classically from tuberculosis but also seen in some fungal infections; its identification prompts systemic workup and infection control measures.

Extracellular deposits beneath the retinal pigment epithelium, appearing as yellow spots; they are a hallmark of age-related macular degeneration and their size and number predict progression.

Growth of abnormal vessels from the choroid through Bruch membrane into the subretinal space, causing hemorrhage, fluid, and scarring; anti-VEGF therapy is the main treatment for neovascular macular degeneration.

Signaling protein induced by hypoxia that promotes vessel growth and permeability; it drives diabetic retinopathy and neovascular macular disease and is the target of intravitreal anti-VEGF drugs.

Drug class such as timolol that lowers intraocular pressure by reducing aqueous production; systemic absorption can cause bronchospasm and bradycardia, so caution is needed in asthma and heart block.

Topical agent such as latanoprost that increases uveoscleral outflow and is first-line for glaucoma; adverse effects include iris darkening, eyelash growth, and periorbital fat atrophy.

Paralysis of the ciliary muscle by antimuscarinic drugs such as cyclopentolate or atropine, abolishing accommodation; used for refraction and to relieve ciliary spasm, with temporary blurred near vision.

Pupil dilation produced by sympathetic activation or by antimuscarinic blockade of the iris sphincter; it can precipitate angle-closure glaucoma in anatomically predisposed eyes.

Statistic estimating the proportion of total variance attributable to differences among groups or raters; used to assess reliability and clustering in ophthalmic measurement and study design.

Range of plausible values for a population parameter, computed from sample data at a stated confidence level; it conveys estimation precision better than a p-value alone.

Number of patients who must receive an intervention for one additional favorable outcome, the reciprocal of absolute risk reduction; it translates trial results into practical clinical impact.

Ethical and legal requirement to disclose diagnosis, proposed treatment, alternatives, and material risks, confirm patient understanding, and obtain voluntary agreement before care or research participation.

Level of care a reasonably prudent clinician with similar training would provide under comparable circumstances; it frames negligence analysis and documentation expectations in malpractice claims.